STUDIES CONCERNING CYTOGENETIC RELATIONSHIP BETWEEN IN VIVO AND CORRESPONDING IN VITRO CELL POPULATIONS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA

被引：4
|
作者：
PEDERSEN, B
机构：
来源：
ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA | 1966年 / 68卷 / 03期
关键词：
D O I：
10.1111/apm.1966.68.3.408
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：408 / &
相关论文
共 32 条
  • [1] CYTOGENETIC STRUCTURE OF ANEUPLOID BLOOD CULTURE CELL POPULATIONS DURING PROGRESSION AND TREATMENT OF CHRONIC MYELOGENOUS LEUKAEMIA
    PEDERSEN, B
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1967, 69 (02): : 192 - &
  • [2] Succesful peripheral blood stem cell mobilisation in patients with chronic myelogenous leukaemia achieving complete cytogenetic response with imatinib
    Tothova, E
    Kafkova, A
    Guman, T
    Stecova, N
    Fricova, M
    Rosocha, J
    BONE MARROW TRANSPLANTATION, 2006, 37 : S229 - S229
  • [3] In vivo and in vitro studies on Anaplasma phagocytophilum infection of the myeloid cells of a patient with chronic myelogenous leukaemia and human granulocytic ehrlichiosis
    Bayard-Mc Neeley, M
    Bansal, A
    Chowdhury, I
    Girao, G
    Small, CB
    Seiter, K
    Nelson, J
    Liveris, D
    Schwartz, I
    Mc Neeley, DF
    Wormser, GP
    Aguero-Rosenfeld, ME
    JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (05) : 499 - 503
  • [4] AUTOLOGOUS VERUS HOMOLOGOUS CULTURE MEDIA IN BLOOD CULTURES FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA . COMPARISON OF CYTOGENETIC PICTURES
    PEDERSEN, B
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1966, 68 (03): : 421 - &
  • [5] The relationship between short-term response and long-term outcomes in patients with chronic phase chronic myelogenous leukaemia
    Taylor, M. J.
    Kan, H. J.
    Davis, C.
    VALUE IN HEALTH, 2007, 10 (03) : A128 - A128
  • [6] T CELLS FROM CHRONIC LYMPHOCYTIC LEUKAEMIA PATIENTS SUPPORT TUMOR CELL SURVIVAL IN VITRO
    Kokhaei, P.
    Mozaffari, F.
    Palma, M.
    Rosmann, E.
    Osterborg, A.
    Mellstedt, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 234 - 235
  • [7] Genomic characterization of Imatinib resistance in CD34+ cell populations from chronic myeloid leukaemia patients
    Joha, Sami
    Dauphin, Veronique
    Lepretre, Frederic
    Corm, Selim
    Nicolini, Franck E.
    Roumier, Christophe
    Nibourel, Olivier
    Grardel, Nathalie
    Maguer-Satta, Veronique
    Idziorek, Thierry
    Figeac, Martin
    Lai, Jean-Luc
    Quesnel, Bruno
    Etienne, Gabriel
    Guilhot, Francois
    Lippert, Eric
    Preudhomme, Claude
    Roche-Lestienne, Catherine
    LEUKEMIA RESEARCH, 2011, 35 (04) : 448 - 458
  • [8] Progenitor cells from patients with advanced phase chronic myeloid leukaemia respond to STI571 in vitro and in vivo
    Marley, SB
    Davidson, RJ
    Lewis, JL
    Nguyen, DX
    Eades, A
    Parker, S
    Goldman, JM
    Gordon, MY
    LEUKEMIA RESEARCH, 2001, 25 (11) : 997 - 1002
  • [9] In vitro topo II-DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia
    Wang, YY
    Zhou, R
    Liliemark, J
    Gruber, A
    Lindemalm, S
    Albertioni, F
    Liliemark, E
    LEUKEMIA RESEARCH, 2001, 25 (02) : 133 - 140
  • [10] Relationship between elevated levels of the alpha 1 acid glycoprotein in chronic myelogenous leukemia in blast crisis and pharmacological resistance to imatinib (Gleevec®) in vitro and in vivo
    Larghero, J
    Leguay, T
    Mourah, S
    Madelaine-Chambrin, I
    Taksin, AL
    Raffoux, E
    Bastie, JN
    Degos, L
    Berthaud, P
    Marolleau, JP
    Calvo, F
    Chomienne, C
    Mahon, FX
    Rousselot, P
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (10) : 1907 - 1913
1234